Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi Larson

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Vaccine|April 20, 2013
Effective vaccine safety systems in all countries: a challenge for more equitable access to immunizationAnanda Amarasinghe, Steve Black, Jan Bonhoeffer, et al.
Vaccine|November 8, 2020
The public's role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United StatesMonica Schoch-Spana, Emily K Brunson, Rex Long, et al.
Wellcome Open Research|November 5, 2019
Social and economic impacts of congenital Zika syndrome in Brazil: Study protocol and rationale for a mixed-methods studyHannah Kuper, Tereza Maciel Lyra, Maria Elisabeth Lopes Moreira, et al.
The Lancet. Infectious Diseases|September 16, 2021
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trialDavid Ishola, Daniela Manno, Muhammed O Afolabi, et al.
The Lancet. Infectious Diseases|September 16, 2021
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trialMuhammed O Afolabi, David Ishola, Daniela Manno, et al.
JAMA Oncology|October 7, 2017
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015, Tomi Akinyemiju, Semaw Abera, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Vaccine|April 20, 2013
Effective vaccine safety systems in all countries: a challenge for more equitable access to immunizationAnanda Amarasinghe, Steve Black, Jan Bonhoeffer, et al.
Vaccine|November 8, 2020
The public's role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United StatesMonica Schoch-Spana, Emily K Brunson, Rex Long, et al.
Wellcome Open Research|November 5, 2019
Social and economic impacts of congenital Zika syndrome in Brazil: Study protocol and rationale for a mixed-methods studyHannah Kuper, Tereza Maciel Lyra, Maria Elisabeth Lopes Moreira, et al.
The Lancet. Infectious Diseases|September 16, 2021
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trialDavid Ishola, Daniela Manno, Muhammed O Afolabi, et al.
The Lancet. Infectious Diseases|September 16, 2021
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trialMuhammed O Afolabi, David Ishola, Daniela Manno, et al.
JAMA Oncology|October 7, 2017
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015, Tomi Akinyemiju, Semaw Abera, et al.
Pageof 7